BBOX1-AS1: A Potential Drug Target and Biomarker (G103695435)

Target Name: BBOX1-AS1

NCBI ID: G103695435

BBOX1-AS1

Other Name(s): BBOX1 antisense RNA 1, transcript variant 1 | BBOX1 antisense RNA 1

BBOX1-AS1: A Potential Drug Target and Biomarker

Introduction

BBOX1-AS1, also known as BBOX1 antisense RNA 1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is derived from the BBOX1 gene, which encodes a protein known for its role in regulating cell growth and differentiation. The RNA molecule is expressed in various tissues and has been shown to play a role in the regulation of cell proliferation, survival, and apoptosis.

Potential Drug Target

The potential drug target for BBOX1-AS1 is its role in cell proliferation and survival. BBOX1-AS1 has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and colorectal cancer. It has also been shown to contribute to the development and progression of various diseases, including neurodegenerative disorders and autoimmune diseases.

One of the reasons for its potential drug target status is its expression in multiple tissues, including the brain, which suggests that it may be involved in the regulation of important cellular processes that are relevant to a wide range of diseases. Additionally, its expression has has been shown to be regulated by various signaling pathways, including TGF-??, which suggests that it may be a target for drugs that are effective in treating conditions that are characterized by uncontrolled cell growth.

Biomarker

BBOX1-AS1 has also been shown to serve as a potential biomarker for various diseases. Its expression has been shown to be altered in a wide range of diseases, including neurodegenerative disorders, autoimmune diseases, and cancer. Additionally, its expression has been shown to be associated with various clinical outcomes, including disease progression and poor prognosis.

Furthermore, the expression of BBOX1-AS1 has been shown to be regulated by various factors, including DNA methylation, histone modification, and post-transcriptional modification. These factors may play a role in the regulation of BBOX1-AS1 expression and its function as a biomarker.

Conclusion

In conclusion, BBOX1-AS1 is a promising drug target and biomarker that has the potential to contribute to the treatment of a wide range of diseases. Its expression in various tissues and its role in the regulation of cell proliferation and survival make it an attractive target for drugs that are effective in treating conditions characterized by uncontrolled cell growth. Additionally, its potential as a biomarker for various diseases and its regulation by various signaling pathways make it an promising tool for the development of new diagnostic tests and therapies.

Protein Name: BBOX1 Antisense RNA 1

The "BBOX1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BBOX1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets